Pierre Fabre Invest Overview
Pierre Fabre Invest is the investment division of the Pierre Fabre Group, specializing in early-stage investments within the biotechnology and pharmaceutical sectors. The firm has made investments in companies such as TOLREMO therapeutics, a Swiss biotechnology firm, and another in France, indicating a focus on European markets.
Is Pierre Fabre Invest the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Pierre Fabre Invest, along with a list of other relevant VCs, is available on Hopohopo.io.
Pierre Fabre Invest
Investment focus
Invest in
- Western Europe 1 / 14
- East Asia 1 / 7
Product type
- Software-enabled hardware
- Consumer goods
- Drugs / Pharma
Industries / verticals
- Beauty & Personal Care
- BioTech & Life Sciences
- Digital & Consumer health
- MedTech & Devices
- PharmaTech
Stages
Seed, Series A
First ticket size
€1,000,000 - €3,000,000
How to approach funds like Pierre Fabre Invest
When engaging Pierre Fabre Invest, founders should highlight differentiated science or technology with clear clinical or therapeutic potential, especially if it addresses unmet medical needs. Demonstrating a strong understanding of regulatory pathways and a credible plan for early validation will resonate, as will evidence of experienced teams with a track record in biotech or pharma. Emphasize how your innovation could complement or strategically align with Pierre Fabre’s broader healthcare ecosystem, as they value synergies that can accelerate development and market access.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
